CTIS.eu › Cities › Poland › Elblag
Elblag
Poland
125 total trials
32 recruiting
2023-509302-30-00
5
2024-11-04
Hypertriglyceridemia
2023-509300-14-00
5
2024-10-31
Severe hypertriglyceridemia (SHTG)
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
2023-506876-28-00
5
2024-08-01
The medical condition we are investigating is type 1 AMI (STEMI and NS
2023-509762-38-00
5
2024-08-01
Respiratory Syncytial Virus Infections
2023-505061-82-01
5
2024-06-17
Alopecia Areata
2022-502781-24-01
5
2024-06-05
ASCVD - Atherosclerotic Cardiovascular Disease
2023-505435-12-00
5
2024-06-04
Asthma
2023-508630-34-00
5
2024-05-28
Overweight
2023-503385-24-00
4
2024-03-12
Asthma
2023-505120-59-00
5
2023-12-19
Moderate to Severe Plaque Psoriasis
2023-505122-34-00
5
2023-12-05
Plaque Psoriasis
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
2024-515027-11-00
4
2023-06-29
Crohn’s disease
2022-500700-22-00
5
2023-05-25
Active Systemic Lupus Erythematosus (SLE)
2022-500953-17-00
4
2023-03-23
Moderately to severely active ulcerative colitis
2023-506924-94-00
5
2023-02-28
Cardiovascular disease
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
2023-506929-11-00
5
2022-10-17
Overweight and obesity
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
2023-506450-20-00
5
2021-11-05
Rheumatoid Arthritis
2023-506257-37-00
5
2021-10-29
Active Psoriatic Arthritis
2023-504715-33-00
5
2021-09-27
Psoriatic Arthritis
Showing 49–72 of 125 trials